From the bench to the bedside: emerging new treatments in multiple myeloma

CS Mitsiades, PJ Hayden, KC Anderson… - Best practice & research …, 2007 - Elsevier
Within the last decade, several novel classes of anti-myeloma therapeutics have become
available. The clinical successes achieved by thalidomide, lenalidomide, and the …
被引用次数：83 相关文章

From the bench to the bedside: emerging new treatments in multiple myeloma.

CS Mitsiades, PJ Hayden, KC Anderson… - Best Practice & …, 2007 - europepmc.org
Within the last decade, several novel classes of anti-myeloma therapeutics have become
available. The clinical successes achieved by thalidomide, lenalidomide, and the …

From the bench to the bedside: emerging new treatments in multiple myeloma

CS Mitsiades, PJ Hayden, KC Anderson… - Best Practice & …, 2007 - infona.pl
Within the last decade, several novel classes of anti-myeloma therapeutics have become
available. The clinical successes achieved by thalidomide, lenalidomide, and the …

[引用][C] From the bench to the bedside: emerging new treatments in multiple myeloma

CS Mitsiades, PJ Hayden, KC Anderson… - Best Practice & …, 2007 - cir.nii.ac.jp
From the bench to the bedside: emerging new treatments in multiple myeloma | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細へ移動 検索フォ恁啶匾動 …

From the bench to the bedside: emerging new treatments in multiple myeloma

CS Mitsiades, PJ Hayden, KC Anderson… - 2007 - hero.epa.gov
Within the last decade, several novel classes of anti-myeloma therapeutics have become
available. The clinical successes achieved by thalidomide, lenalidomide, and the …

From the bench to the bedside: emerging new treatments in multiple myeloma

CS Mitsiades, PJ Hayden… - Best practice & …, 2007 - pubmed.ncbi.nlm.nih.gov
Within the last decade, several novel classes of anti-myeloma therapeutics have become
available. The clinical successes achieved by thalidomide, lenalidomide, and the …
[HTML] nih.gov

[HTML][HTML] From the bench to the bedside: emerging new treatments in multiple myeloma

CS Mitsiades, PJ Hayden, KC Anderson… - Best practice & …, 2007 - ncbi.nlm.nih.gov
Within the last decade, several novel classes of anti-myeloma therapeutics have become
available. The clinical successes achieved by thalidomide, lenalidomide, and the …

[引用][C] From the bench to the bedside: emerging new treatments in multiple myeloma

CS MITSIADES, PJ HAYDEN, KC ANDERSON… - Baillière's best practice …, 2007 - Elsevier